Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2853
Source ID: NCT01340768
Associated Drug: Sitagliptin
Title: Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)
Acronym:
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT01340768/results
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG: Sitagliptin|DRUG: Sulfonylurea|DRUG: Metformin
Outcome Measures: Primary: Percentage of Participants With at Least One Symptomatic Hypoglycemic Event, Symptomatic hypoglycemic events were based on the participants own self-reported symptoms (for example, but not limited to the following: faintness, headache, confusion, anxiety, sweating, tremor, palpitations, nausea, pallor, dizziness, hunger, sudden behavioral change)., Up to 30 days (Day 1 through last day of Ramadan) | Secondary: Percentage of Participants With at Least One Symptomatic or Asymptomatic Hypoglycemic Event, Symptomatic hypoglycemic events were based on the participants own self-reported symptoms (for example but not limited to the following: faintness, headache, confusion, anxiety, sweating, tremor, palpitations, nausea, pallor, dizziness, hunger, sudden behavioral change). Asymptomatic hypoglycemic events were based on self-monitored finger-stick blood glucose level., Up to 30 days (Day 1 through last day of Ramadan)
Sponsor/Collaborators: Sponsor: Merck Sharp & Dohme LLC
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 870
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2010-06-22
Completion Date: 2011-09-21
Results First Posted: 2012-10-08
Last Update Posted: 2017-06-05
Locations:
URL: https://clinicaltrials.gov/show/NCT01340768